STAT Plus: Generic group fails again to block California law that bans pay-to-delay deals
A federal appeals court denied a bid by a pharmaceutical industry trade group to block a closely watched California law that bans so-called pay-to-delay deals between drug makers, a contentious issue that has factored into the larger debate over the cost of prescription medicines.
The ruling, which was issued Friday, came in response to a lawsuit by the Association for Accessible Medicines after California passed its law last fall. The state became the first in the nation to outlaw pay-to-delay deals, and California officials explained the step was necessary in order to prevent drug companies from thwarting competition and maintaining higher prices.
Continue to STAT Plus to read the full story…
